Early T Cell Precursor Leukemia Presenting With Superior Vena Cava Syndrome and Cardiac Tamponade
- PMID: 34396298
- PMCID: PMC8352309
- DOI: 10.1016/j.jaccao.2020.10.009
Early T Cell Precursor Leukemia Presenting With Superior Vena Cava Syndrome and Cardiac Tamponade
Keywords: CMR, cardiac magnetic resonance; CT, computed tomographic; DOAC, direct oral anticoagulant agent; FDG, fluorodeoxyglucose; LMWH, low–molecular weight heparin; PET, positron emission tomographic; SVC, superior vena cava; cardiac tamponade; precursor T cell lymphoma; superior vena cava syndrome; tumor thrombosis.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Wilson L.D., Detterbeck F.C., Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356:1862–1869. - PubMed
-
- Rice T.W., Rodriguez R.M., Light R.W. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37–42. - PubMed
-
- Sonavane S.K., Milner D.M., Singh S.P., Abdel Aal A.K., Shahir K.S., Chaturvedi A. Comprehensive imaging review of the superior vena cava. Radiographics. 2015;35:1873–1892. - PubMed
-
- Motwani M., Kidambi A., Herzog B.A., Uddin A., Greenwood J.P., Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268:26–43. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
